Send feedback

ELAC2 p.Pro26fs

c.77_89del · VCV3616468

Pathogenic Single submitter
Classification
Pathogenic
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
Conditions
1
combined oxidative phosphorylation defect type 17

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 1 of 24
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 0.71GERP 1, phastCons 0.99

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Variant & gene context

Gene
ELAC2
Protein
p.Pro26fs
Coding
c.77_89del
MANE Select
NM_018127
Type
Deletion
Location
chr17:13017859 (GRCh38)
Gene constraint
LOEUF 1.02 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 82.81 · 10 PDB
Residue 26
the 'disordered' region
Full ELAC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

combined oxidative phosphorylation defect type 17 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Combined oxidative phosphorylation defect type 17 (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/elac2-p-pro26fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown